XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Accounting Policies [Abstract]    
Net loss attributable to Sanara MedTech common shareholders $ (1,181,744) $ (1,836,957)
Weighted average shares used to compute diluted net loss per share 6,816,646 4,751,941
Basic and diluted net loss per share attributable to common shareholders $ (0.17) $ (0.39)